NGSベースRNAシーケンシングの世界市場レポート 2025年

NGSベースRNAシーケンシングの市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR25.2％で104億米ドルに成長します。予測期間の成長は、臨床診断、国際共同研究、倫理的・規制的枠組み、農業・環境調査、グリーンゲノミクスに起因しています。予測期間の主な動向には、シングルセルRNAシーケンス（scRNA-seq）、空間トランスクリプトミクス、エピトランスクリプトミクス、マルチオミクス統合、持続可能な農業などがあります。

精密医療の拡大がNGSベースRNAシーケンシング市場の成長を促進しています。精密医療は、ヘルスケアプロバイダーがオーダーメイドの治療計画を立て、患者の状態を遺伝子的に理解した上で意思決定することを支援します。がんなどの重篤な疾患に対処するための精密医療への注目が高まっています。NGSベースのRNAシーケンシングは、疾患の根本的な原因を特定し、特定の精密治療を推奨するのに役立っています。例えば、2023年2月、米国の非営利団体である個別化医療連合（PMC）の報告書によると、2021年に新たに承認された新規分子医薬品（NME）の35％が個別化医薬品でした。2022年に新たに承認されたのは12品目であり、過去8年間一貫して新薬承認の4分の1以上を占めており、10年前の10％未満から大幅に増加しています。プレシジョンメディシンの需要が伸び続けるにつれ、NGSベースRNAシーケンシングの需要も増加します。

拡大する製薬業界が、NGSベースRNAシーケンシング市場の今後の成長を牽引すると予想されます。製薬業界には、公的機関と民間機関の両方による医薬品や医薬品の発見、開発、生産が含まれます。NGSベースRNAシーケンシングは、遺伝子発現の徹底的な分析、潜在的な創薬ターゲットの特定、薬物反応の評価、疾患メカニズムの解明などに活用され、分子プロセスのより深い理解を通じて創薬と医薬品開発を強化しています。例えば、2024年9月、米国を拠点とするABA療法サービスのプロバイダーであるCross River Therapy社が発表した統計によると、米国の製薬業界の売上高は5,500億米ドルで、2021年には米国人が5,769億米ドルを薬に費やしたことが明らかになった。2025年には6,050億米ドルから6,350億米ドルに増加すると予測されています。その結果、製薬業界の成長がNGSベースRNAシーケンシング市場の拡大を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のNGSベースRNAシーケンシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のNGSベースRNAシーケンシング市場：成長率分析
• 世界のNGSベースRNAシーケンシング市場の実績：規模と成長, 2019-2024
• 世界のNGSベースRNAシーケンシング市場の予測：規模と成長, 2024-2029, 2034F
• 世界のNGSベースRNAシーケンシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のNGSベースRNAシーケンシング市場：製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• サンプル調製製品
• シーケンシングプラットフォームと消耗品
• シーケンシングサービス
• データの分析、保存、管理
• 世界のNGSベースRNAシーケンシング市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成による配列決定
• イオン半導体シーケンシング
• 単一分子リアルタイムシーケンシング
• ナノポアシーケンシング
• 世界のNGSベースRNAシーケンシング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 発現プロファイリング解析
• 小さなRNAシーケンシング
• De Novoトランスクリプトームアセンブリ
• 変異呼び出しとトランスクリプトームエピジェネティクス
• 世界のNGSベースRNAシーケンシング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 研究と学術
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• その他のエンドユーザー
• 世界のNGSベースRNAシーケンシング市場：サンプル調製製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• RNA抽出キット
• 図書館準備キット
• 逆転写キット
• 品質管理試薬
• 世界のNGSベースRNAシーケンシング市場：シーケンシングプラットフォームと消耗品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シーケンシング機器
• シーケンシング消耗品
• 世界のNGSベースRNAシーケンシング市場：シーケンスサービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 契約シーケンスサービス
• カスタムライブラリ準備サービス
• コンサルティングおよび実験設計サービス
• 世界のNGSベースRNAシーケンシング市場：データ分析、保存、管理のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオインフォマティクスソフトウェア
• データ分析サービス
• クラウドベースのデータストレージソリューション
• データ管理プラットフォーム

第7章 地域別・国別分析

• 世界のNGSベースRNAシーケンシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のNGSベースRNAシーケンシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• NGSベースRNAシーケンシング市場：競合情勢
• NGSベースRNAシーケンシング市場：企業プロファイル
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • BGI Group Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• QIAGEN N.V.
• PerkinElmer Inc.
• Eurofins Scientific SE
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Hamilton Company
• Takara Bio Inc.
• Tecan Trading AG
• GENEWIZ Inc.
• Novogene Corporation
• Macrogen Inc.
• Zymo Research Corp.
• Lexogen GmbH
• Partek Incorporated
• GATC Biotech AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• NGSベースRNAシーケンシング市場2029：新たな機会を提供する国
• NGSベースRNAシーケンシング市場2029：新たな機会を提供するセグメント
• NGSベースRNAシーケンシング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

The NGS-based RNA sequencing market research report is one of a series of new reports from The Business Research Company that provides NGS-based RNA sequencing market statistics, including NGS-based RNA sequencing industry global market size, regional shares, competitors with a NGS-based RNA sequencing market share, detailed NGS-based RNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the NGS-based RNA sequencing industry. This NGS-based RNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The NGS-based RNA-sequencing market size has grown exponentially in recent years. It will grow from $3.41 billion in 2024 to $4.23 billion in 2025 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to genomic research initiatives, reduction in sequencing costs, drug discovery and development, personalized medicine, increasing ngs adoption.

The NGS-based RNA-sequencing market size is expected to see exponential growth in the next few years. It will grow to $10.4 billion in 2029 at a compound annual growth rate (CAGR) of 25.2%. The growth in the forecast period can be attributed to clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, green genomics. Major trends in the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, sustainable agriculture.

The expansion of precision medicine is propelling the growth of the NGS-based RNA sequencing market. Precision medicine assists healthcare providers in creating tailored treatment plans and making decisions based on a genetic understanding of the patient's condition. There is an increasing focus on precision medicines for addressing serious diseases such as cancer. NGS-based RNA sequencing is instrumental in identifying the underlying causes of diseases and recommending specific precision treatments. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently accounted for at least a quarter of new drug approvals over the past eight years, marking a substantial rise from less than 10% a decade ago. As the demand for precision medicines continues to grow, so too will the demand for NGS-based RNA sequencing.

The expanding pharmaceutical industry is anticipated to drive the growth of the NGS-based RNA sequencing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both public and private organizations. NGS-based RNA sequencing is utilized within this sector to conduct thorough analyses of gene expression, identify potential drug targets, evaluate drug responses, and comprehend disease mechanisms, thereby enhancing drug discovery and development through a better understanding of molecular processes. For instance, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, revealed that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medications in 2021. Projected spending is expected to rise to between $605 billion and $635 billion by 2025. Consequently, the growth of the pharmaceutical industry is propelling the expansion of the NGS-based RNA sequencing market.

A notable trend in the NGS-based RNA sequencing market is the formation of strategic partnerships. Companies are increasingly engaging in partnerships with NGS-based RNA sequencing firms to enter new markets and leverage collective resources. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA) partnered with multiple industry and academic collaborators to enhance diagnostic capabilities for respiratory RNA viruses. Such strategic partnerships contribute to bolstering the capacity to respond swiftly to public health emergencies and advance diagnostic capabilities.

Major companies in the NGS-based RNA-sequencing market are concentrating on innovative products to meet the growing demand for RNA sequencing. One such innovation is the development of ultra-fast RNA methods for molecular testing and life science research applications, offering exceptionally rapid RNA sequencing or analysis. In March 2022, Quantabio launched the sparQ RNA-Seq HMR Kit, an ultra-fast RNA library preparation tool designed for precision oncology applications. This kit enables the generation of high-quality NGS sequencer-ready libraries from intact or degraded samples in a single day.

In October 2022, Illumina Inc., a US-based company specializing in DNA sequencing and array-based technology, announced a collaboration with GenoScreen. This partnership seeks to enhance access to genomic testing for multidrug-resistant tuberculosis (MDR-TB), facilitating faster and more effective detection of drug resistance to aid in the global fight against TB, particularly in countries severely affected by the disease. GenoScreen is a France-based company focused on sequencing, genotyping, and bioinformatics.

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in NGS-based RNA sequencing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the NGS-based RNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
• 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
• 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly; Variant Calling and Transcriptome Epigenetics
• 4) By End User: Research & Academia; Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
• 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
• 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
• 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. NGS-Based RNA-Sequencing Market Characteristics

3. NGS-Based RNA-Sequencing Market Trends And Strategies

4. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global NGS-Based RNA-Sequencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global NGS-Based RNA-Sequencing Market Growth Rate Analysis
• 5.4. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM)

6. NGS-Based RNA-Sequencing Market Segmentation

• 6.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Preparation Products
• Sequencing Platforms and Consumables
• Sequencing Services
• Data Analysis, Storage, and Management
• 6.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
• Nanopore Sequencing
• 6.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Expression Profiling Analysis
• Small RNA Sequencing
• De Novo Transcriptome Assembly
• Variant Calling and Transcriptome Epigenetics
• 6.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research & Academia
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users
• 6.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA Extraction Kits
• Library Preparation Kits
• Reverse Transcription Kits
• Quality Control Reagents
• 6.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing Instruments
• Sequencing Consumables
• 6.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Sequencing Services
• Custom Library Preparation Services
• Consultation And Experimental Design Services
• 6.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioinformatics Software
• Data Analysis Services
• Cloud-Based Data Storage Solutions
• Data Management Platforms

7. NGS-Based RNA-Sequencing Market Regional And Country Analysis

• 7.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific NGS-Based RNA-Sequencing Market

• 8.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China NGS-Based RNA-Sequencing Market

• 9.1. China NGS-Based RNA-Sequencing Market Overview
• 9.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India NGS-Based RNA-Sequencing Market

• 10.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan NGS-Based RNA-Sequencing Market

• 11.1. Japan NGS-Based RNA-Sequencing Market Overview
• 11.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia NGS-Based RNA-Sequencing Market

• 12.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia NGS-Based RNA-Sequencing Market

• 13.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea NGS-Based RNA-Sequencing Market

• 14.1. South Korea NGS-Based RNA-Sequencing Market Overview
• 14.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe NGS-Based RNA-Sequencing Market

• 15.1. Western Europe NGS-Based RNA-Sequencing Market Overview
• 15.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK NGS-Based RNA-Sequencing Market

• 16.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany NGS-Based RNA-Sequencing Market

• 17.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France NGS-Based RNA-Sequencing Market

• 18.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy NGS-Based RNA-Sequencing Market

• 19.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain NGS-Based RNA-Sequencing Market

• 20.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe NGS-Based RNA-Sequencing Market

• 21.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
• 21.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia NGS-Based RNA-Sequencing Market

• 22.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America NGS-Based RNA-Sequencing Market

• 23.1. North America NGS-Based RNA-Sequencing Market Overview
• 23.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA NGS-Based RNA-Sequencing Market

• 24.1. USA NGS-Based RNA-Sequencing Market Overview
• 24.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada NGS-Based RNA-Sequencing Market

• 25.1. Canada NGS-Based RNA-Sequencing Market Overview
• 25.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America NGS-Based RNA-Sequencing Market

• 26.1. South America NGS-Based RNA-Sequencing Market Overview
• 26.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil NGS-Based RNA-Sequencing Market

• 27.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East NGS-Based RNA-Sequencing Market

• 28.1. Middle East NGS-Based RNA-Sequencing Market Overview
• 28.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa NGS-Based RNA-Sequencing Market

• 29.1. Africa NGS-Based RNA-Sequencing Market Overview
• 29.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

• 30.1. NGS-Based RNA-Sequencing Market Competitive Landscape
• 30.2. NGS-Based RNA-Sequencing Market Company Profiles
  • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

31. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

• 31.1. QIAGEN N.V.
• 31.2. PerkinElmer Inc.
• 31.3. Eurofins Scientific SE
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. F. Hoffmann-La Roche Ltd.
• 31.6. Hamilton Company
• 31.7. Takara Bio Inc.
• 31.8. Tecan Trading AG
• 31.9. GENEWIZ Inc.
• 31.10. Novogene Corporation
• 31.11. Macrogen Inc.
• 31.12. Zymo Research Corp.
• 31.13. Lexogen GmbH
• 31.14. Partek Incorporated
• 31.15. GATC Biotech AG

32. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

34. Recent Developments In The NGS-Based RNA-Sequencing Market

35. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

• 35.1 NGS-Based RNA-Sequencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 NGS-Based RNA-Sequencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 NGS-Based RNA-Sequencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer